Article
Questions Remain About Nirsevimab’s Impact
November 16, 2023
The new monoclonal antibody nirsevimab may radically change incidence and outcomes for respiratory syncytial virus (RSV) infections in young pediatric patients, especially when combined with the...
News
Moderna warns of material drop in vaccine efficacy against Omicron
December 1, 2021
“There is no world, I think, where [the effectiveness] is the same level … we had with Delta.”
News
CDC: Thirty percent of hospital workers in U.S. still unvaccinated
November 19, 2021
Health care personnel “are not fully immune from vaccine misinformation.”
![1]()
News
FDA authorizes Pfizer’s COVID-19 vaccine for kids
October 29, 2021
As soon as the CDC’s director signs off on those recommendations, children can get the shots, perhaps as early as Nov. 3.
News
U.K. study finds vaccinated people easily transmit Delta variant in households
October 29, 2021
The researchers underlined that did not weaken the argument for vaccination as the best way of reducing serious illness from COVID-19 and said booster shots were required.
News
FDA panel votes to approve Pfizer’s vaccine for children
October 26, 2021
If the FDA follows the recommendation, as it typically does, ...the shots could be available within days.
News
Americans wonder: Which COVID-19 booster is best?
October 26, 2021
Americans recently were handed a big decision when it comes to getting a COVID-19 vaccine booster.
News
Valneva jumps on positive results for COVID-19 vaccine candidate
October 19, 2021
The vaccine generated similar seroconversion rates and slightly higher neutralizing antibody titers compared with AstraZeneca’s Vaxzevria.
![1]()
News
FDA panel backs second dose for Johnson & Johnson vaccine recipients
October 15, 2021
It will be up to a Centers for Disease Control and Prevention (CDC) panel to make more specific recommendations for who might need another shot.
![1]()
News
FDA advisors vote to recommend Moderna boosters
October 14, 2021
The panel voted to authorize a 50 milligram dose — half the dose used in the primary series of shots — to boost immunity against COVID-19 at least 6 month after the second dose.
